RYTHM
Licenses cannabis brands and sells hemp-derived THC consumer products.
Something off on this page? Send us feedback.
Profile
Owns cannabis and hemp brand IP, licensing specified brands to Green Thumb. It also sells hemp-derived THC products under its portfolio of brands.
Owns a portfolio of hemp-derived THC products and cannabis brand intellectual property, including RYTHM, incredibles, Dogwalkers, Beboe, &Shine, Doctor Solomon’s, Good Green, and Señorita. Its consumer-products business includes hemp-derived THC beverages across its branded portfolio.
Licenses specified brands to Green Thumb, which manufactures and distributes them. Green Thumb is also a major shareholder and has board representation, making the relationship central to the operating model. The company exited its legacy cultivation-equipment and extraction businesses before adopting the current IP-owner, licensing, and consumer-products model. The portfolio reflects the issuer's well-being positioning.
Company facts
Categories
Key statistics
Year to date +4.8% · Average volume (30d) 12.2K
Analysts
No analyst consensus on record.
Earnings
EPS
Revenue
History
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Next session |
|---|---|---|---|---|---|---|---|
| Aug 4, 2026Q2 FY26 | −$945.00 | $0.09 | +100.0% | $5.8M | $23.0M | +296.9% | +23.20% |
| May 5, 2026Q1 FY26 | −$945.00 | $1.33 | +100.1% | $5.8M | $13.3M | +129.1% | +8.54% |
| Mar 3, 2026Q4 FY25 | — | −$6.63 | — | $66.4M | $10.7M | −83.9% | +2.05% |
| Nov 7, 2025Q3 FY25 | — | −$5.31 | — | — | $4.0M | — | −16.98% |
Financial highlights
| 12 quarters | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | |
|---|---|---|---|---|---|---|---|
| Revenue | $538.0K | $2.0M | $4.0M | $10.7M | $13.3M | $23.0M | |
| Gross profit | −$246.0K | $682.0K | $1.4M | $8.0M | $7.0M | $18.5M | |
| Operating income | −$3.7M | −$6.8M | −$8.9M | −$4.5M | −$4.0M | $1.9M | |
| Net income | −$1.6M | −$7.4M | −$10.7M | −$13.6M | $19.9M | $1.2M | |
| Diluted EPS | −$2.66 | −$3.73 | −$5.33 | −$6.62 | $0.63 | $0.09 | |
| Gross margin | -45.7% | 33.4% | 34.0% | 75.5% | 52.3% | 80.5% | |
| Operating margin | -687.9% | -332.9% | -219.8% | -42.0% | -30.4% | 8.4% |
Fiscal years (4-quarter sums)FY21 $59.9M · FY22 $58.3M · FY23 $16.9M · FY24 $4.1M · FY25 $17.3M
Revenue by product · Q2 FY26
Balance sheet, Jun 30, 2026Cash & short-term investments $41.9M · Total debt $80.6M · Total assets $135.4M · Shareholders' equity $39.1M
Dividends
No dividends on record.
Ownership
Shares outstanding 2.15M · Float 1.29M · 60.1% free float
Top shareholders13F · 13D/G · Form 4
| Holder | Shares | % outstanding | Form | Filed |
|---|---|---|---|---|
| Rslgh, LLC | 13.29M | 89.90% | 13D | Aug 11, 2026 |
| Mgmt, LLC | 6.86M | 49.99% | 13D | Nov 13, 2024 |
| Double Or Nothing LLC | 228.0K | 9.90% | 13G | Feb 5, 2026 |
| Benjamin Kovler · director, officer: Interim CEO | 66.3K | 3.08% | Form 4 | Nov 20, 2025 |
| Ieq Capital, LLC | 34.9K | 1.62% | 13F | May 15, 2026 |
Insider tradesForm 4
| Date | Insider | Role | Shares | Avg price |
|---|---|---|---|---|
| Jun 17, 2026 | Armon Vakili | director | −2,250 | $26.52 |
| Jun 16, 2026 | Max Holtzman | director | −5,000 | $26.00 |
| Jun 11, 2026 | Timothy Mahoney | director | −5,000 | $26.34 |
| Sep 25, 2025 | Benjamin Kovler | director, officer: Interim CEO | +1,000 | $37.08 |
| Sep 19, 2025 | Benjamin Kovler | director, officer: Interim CEO | +1,000 | $39.99 |
Peers
- Tilray Brands
Cannabis brands and beverage-scale consumer distribution
- Canopy Growth
Branded cannabis and hemp products, including U.S. operations
- Cronos Group
Adult-use cannabis brands with leading edible-product positions
- Organigram Global
Canadian recreational cannabis brands across edibles and vapes
CompareAfter-hours close
| Company | Price | Change | |||||
|---|---|---|---|---|---|---|---|
| RYTHM | $23.35 | +0.86% | $49.8M | — | — | 1.0 | +1,027.4% |
| Tilray Brands | $4.59 | +0.17% | $513.3M | — | — | 0.4 | +25.5% |
| Canopy Growth | $0.9900 | −1.88% | $421.9M | — | — | 0.8 | +8.4% |
| Cronos Group | $3.38 | +0.14% | $1.26B | 18.7 | 56.3 | 7.0 | +63.8% |
| Organigram Global | $1.20 | −1.99% | $171.0M | 2.7 | 49.6 | 0.7 | +43.3% |
| Median | 10.7 | 52.9 | 0.8 | +34.4% |